跳至主要内容
临床试验/NL-OMON39985
NL-OMON39985招募中不适用

Prospective study on the metabolic and linear growth effects of growh hormone treatment in children with Kabuki Syndrome - Metabolic effects of Growth Hormone

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 11(—)

入选标准

  • -Children with the KDM6A orKMT2D (MLL2) mutation.;-Children who meet at least four out of five KS characteristics:;#Facial features: long palpebral fissures with eversion of outer third, arched eyebrows with sparse outer half, prominent and/or misshapen ears, and depressed nasal tip.;#Skeletal abnormalities.;#Intellectual disability (mild to moderate).;#Postnatal short stature.;#Abnormalities of dermal ridges.;-Informed consent.;-Age >= four years.

排除标准

  • -Children with a chronological or bone age greater than 8 years for girls and 10 years for boys, because of the influence of puberty.;-Extremely low dietary intake (less than minimal required intake for age according to WHO criteria). ;-Use of medication that might interfere with growth during GH therapy, such as corticosteroids and sex steroids.

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验